RxDoctor Payments Data

Brooke Smith, PA

Physician Assistant · Williamsport, PANPI 1194441246

Payments from drug & device makers

$4,294in general payments, 2019–2025

Across 259 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$775
  • Lilly USA, LLC$702
  • AbbVie$647
  • AstraZeneca$446
  • GSK$364
  • Pfizer$323
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,294 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$32,627
Medicare patients
114
Services billed
677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide85$94,514
EliquisApixaban59$52,636
TrulicityDulaglutide33$31,065
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$31,000
VraylarCariprazine Hcl20$26,813
OzempicSemaglutide22$23,365
JanuviaSitagliptin Phosphate21$15,220
GemtesaVibegron15$10,963
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,071
MyrbetriqMirabegron13$7,650
Breo ElliptaFluticasone/Vilanterol16$6,406
NexiumEsomeprazole Magnesium14$3,788
Rosuvastatin Calcium191$2,870
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$2,785
Albuterol Sulfate HfaAlbuterol Sulfate72$2,775

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$702$125,578118 claims
PfizerEliquis$323$52,63659 claims
GSKTrelegy Ellipta, Breo Ellipta$364$37,40660 claims
AbbVieVraylar$647$26,81320 claims
Novo NordiskOzempic$775$23,36522 claims
MerckJanuvia$43$15,22021 claims
AstraZenecaBreztri Aerosphere, Nexium$446$13,85930 claims
Astellas Pharma US IncMyrbetriq$24$7,65013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Williamsport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →